Core Biogenesis
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- $14M
Investors
- 5
About Core Biogenesis
Founded in 2020 in France, Core Biogenesis focuses on bioproduction solutions for the life sciences sector. The company was established by Alexandre Reeber, Chouaib MEZIADI, and Maurice Moloney.Core Biogenesis specializes in the bioproduction of high-value recombinant proteins and peptides, primarily designed for use in the life sciences and skincare sectors. Utilizing proprietary platform technology, the company employs plants as biofactories, allowing for precise production of peptides and proteins within the plant's oleosomes. This approach delivers advanced solutions in anti-aging skincare and regenerative medicine, catering particularly to markets in Europe and North America where demand for biotechnological ingredients is growing.Core Biogenesis generates revenue through partnerships and direct sales of its bioproduced proteins and peptides to clients in the life science and skincare industries. The business model is primarily B2B, collaborating with skincare brands that formulate products using its proprietary ingredients. Pricing structures are customized based on client needs and product specifications, ensuring competitive offerings. The company plans to enhance its product line with upcoming developments aimed at addressing market needs in life sciences and skincare. Core Biogenesis intends to penetrate new markets and geographic regions, particularly increasing its presence in North America by the end of 2023.
Who invested in Core Biogenesis
5 investors across 2 rounds
See all investors in Core Biogenesis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Core Biogenesis
Who invested in Core Biogenesis?
Core Biogenesis has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Core Biogenesis raised?
Core Biogenesis has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Core Biogenesis last raise money?
Core Biogenesis's most recent round on record is a Series A, in Jun 2022.
What does Core Biogenesis do?
Founded in 2020 in France, Core Biogenesis focuses on bioproduction solutions for the life sciences sector.
Where is Core Biogenesis headquartered?
Core Biogenesis is headquartered in France.
Which VCs invest in companies like Core Biogenesis?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Core Biogenesis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Core Biogenesis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.